Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2011 Jul 12.
Published in final edited form as: Ann Rheum Dis. 2010 Apr;69(4):625–626. doi: 10.1136/ard.2009.113183

Genetic variants of STAT4 associated with rheumatoid arthritis in persons of Asian and European ancestry do not replicate in African-Americans

James M Kelley 1, Laura B Hughes 1, Ashima Malik 1, Maria I Danila 1, Yuanqing Edberg 1, Graciela S Alarcón 1, Doyt L Conn 2, Beth L Jonas 3, Leigh F Callahan 3, Edwin A Smith 4, Richard D Brasington Jr 5, Jeffrey C Edberg 1, Robert P Kimberly 1, Larry W Moreland 1,6, S Louis Bridges Jr 1
PMCID: PMC3133745  NIHMSID: NIHMS302644  PMID: 20237121

Rheumatoid arthritis (RA) was recently genetically associated with signal transducer and activator of transcription 4 (STAT4) in Caucasians [1]. This study included over 6,000 participants to produce an odds ratio of 1.32 at rs7574865 (p = 2.8 × 10−7). Three other single nucleotide polymorphisms (SNPs) located in intron 3 of STAT4 (rs8179673, rs10181656, rs6752770), 3 SNPs in strong linkage disequilibrium with rs7574865 (r2 = 1.0; rs7582694, rs7568275, rs11889341), and a haplotype driven by the T allele of rs7574865 also associated with RA susceptibility [1]. Association with rs7574865 replicated in several Asian and European-based populations. See Table 1. Since racial/ethnic differences have been observed at RA susceptibility loci, including CTLA4, PADI4, PTPN22, RUNX1, and SLC22A4, we aimed to determine if an association with these STAT4 markers and RA susceptibility is consistent in African-Americans.

Table 1. Previously Published Genetic Associations with the T allele of rs7574865 and Susceptibility to Rheumatoid Arthritis.

Studies report that they did not overlap patient enrollment with previous studies if examining the same population [5]. Both populations from North American were of European ancestry.

Population Number of Patients Number of Controls P Value Odds Ratio (95% Confidence Interval) Study
African-American 723 660 0.23 1.22 (0.91–1.63) Current
Columbia 274 421 0.01 1.36 (1.08–1.71) [2]
Greece 311 344 2.0 × 10−4 1.90 (1.46–2.50) [3]
Japan 3567 2199 8.4 × 10−9 1.27 (1.17–1.37) [4]
Netherlands 920 924 0.03 1.45 (1.21–1.73) [5]
North America 1013 1326 6.3 × 10−4 1.28 (1.11–1.47) [1]
North America 607 1309 8.3 × 10−5 1.37 (1.17–1.60) [1]
South Korea 1123 1008 6.5 × 10−3 1.27 (1.11–1.45) [6]
Spain 971 1370 1.0 × 10−3 1.26 (1.09–1.45) [5]
Spain 575 723 1.2 × 10−6 1.59 (1.07–1.55) [7]
Sweden 1529 881 0.02 1.18 (1.02–1.36) [1]
Sweden 288 288 0.03 1.35 (1.03–1.77) [5]
United Kingdom 3399 3024 1.4 × 10−4 1.17 (1.08–1.28) [8]

We used ABI TaqMan allelic discrimination assays to genotype rs8179673, rs10931481, rs11889341, rs7574865, rs10181656, and rs10207044 in 723 African-American RA patients and 690 African-American controls from the Consortium for the Longitudinal Evaluation of African-Americans with Early Rheumatoid Arthritis (CLEAR) Registry as described previously [9]. All participants were recruited with informed consent under approval of an Institutional Review Board. Chi square tests were performed on GraphPad Prism v4.03 (San Diego, CA).

We did not observe a genetic association with rs7574865 (χ2 p = 0.23) or with the other previously associated SNPs. See Table 2. No association was found regardless of stratification by HLA-DRB1 allele or anti-CCP antibody status – factors known to influence genetic association with RA susceptibility.

Table 2. Lack of Association of STAT4 SNPs with Susceptibility to Rheumatoid Arthritis.

MAF – minor allele frequency. YRI – HapMap Yoruban Population. CEPH – HapMap Caucasian Population. Position reflects the genomic location in NCBI contig NT_005403.16. P values are for the comparison of MAF in African-American (Af-Am) RA patients compared to MAF Af-Am controls.

SNP Minor Allele Position MAF Af-Am RA Patients MAF Af-Am Controls MAF - YRI MAF - CEPH χ2 p value
rs11889341 T 42153159 0.141 0.133 0.161 0.208 0.70
rs10931481 G 42164269 0.364 0.352 0.383 0.325 0.24
rs7574865 T 42174050 0.149 0.133 0.158 0.208 0.23
rs8179673 C 42178758 0.157 0.142 0.143 0.213 0.29
rs10181656 G 42179296 0.158 0.142 0.158 0.217 0.25

Since our study population is African-American, our findings may be complicated by possible confounding due to population admixture. We cannot assess local admixture among this group of STAT4 SNPs given the absence of ancestry informative markers in this localized region; however, the lack of large differences in minor allele frequencies between HapMap populations reduces the likelihood of admixture confounding. See Table 2. This study is also smaller than some collections [1] and is subsequently less powered to detect a genetic association. Yet, our study is comparable (or even larger) in size than several studies that previously detected an association with these STAT4 markers [2, 3, 5, 7]. Furthermore, when performing a power calculation using a similar odds ratio to the previous association [1], there is only a 10% chance of a false negative result (α=0.05).

To date, the association of rs7574865 with susceptibility to RA has been replicated in all populations studied, including those of Asian and European descent[1]. See Table 1. We are the first to explore this susceptibility marker in African-Americans and do not reproduce the finding. Given the limited region of the the gene that we examined, it is possible that another region of STAT4 associates with RA susceptibility in populations of African ancestry. Regardless, the ethnic-based differential association of specific STAT4 markers with RA susceptibility suggests a need for additional study into the genetics of this entire gene in multiple populations.

Acknowledgments

This work was supported by NIH N01 AI40068, N01 AR02247, P01 AR49084, R01 AR51394, and NIH GCRC/CTSA grants M01 RR00032, U54 RR025777 (University of Alabama at Birmingham) and M01 RR 000046 (University of North Carolina).

References

  • 1.Remmers EF, Plenge RM, Lee AT, Graham RR, Hom G, Behrens TW, et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med. 2007 Sep 6;357(10):977–986. doi: 10.1056/NEJMoa073003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Palomino-Morales RJ, Rojas-Villarraga A, Gonzalez CI, Ramirez G, Anaya JM, Martin J. STAT4 but not TRAF1/C5 variants influence the risk of developing rheumatoid arthritis and systemic lupus erythematosus in Colombians. Genes Immun. 2008 Jun;9(4):379–382. doi: 10.1038/gene.2008.30. [DOI] [PubMed] [Google Scholar]
  • 3.Zervou MI, Mamoulakis D, Panierakis C, Boumpas DT, Goulielmos GN. STAT4: a risk factor for type 1 diabetes? Hum Immunol. 2008 Oct;69(10):647–650. doi: 10.1016/j.humimm.2008.07.004. [DOI] [PubMed] [Google Scholar]
  • 4.Kobayashi S, Ikari K, Kaneko H, Kochi Y, Yamamoto K, Shimane K, et al. Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population. Arthritis Rheum. 2008 Jul;58(7):1940–1946. doi: 10.1002/art.23494. [DOI] [PubMed] [Google Scholar]
  • 5.Orozco G, Alizadeh BZ, Delgado-Vega AM, Gonzalez-Gay MA, Balsa A, Pascual-Salcedo D, et al. Association of STAT4 with rheumatoid arthritis: a replication study in three European populations. Arthritis Rheum. 2008 Jul;58(7):1974–1980. doi: 10.1002/art.23549. [DOI] [PubMed] [Google Scholar]
  • 6.Lee HS, Remmers EF, Le JM, Kastner DL, Bae SC, Gregersen PK. Association of STAT4 with Rheumatoid Arthritis in the Korean Population. Mol Med. 2007 Sep-Oct;13(9–10):455–460. doi: 10.2119/2007-00072.Lee. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Martinez A, Varade J, Marquez A, Cenit MC, Espino L, Perdigones N, et al. Association of the STAT4 gene with increased susceptibility for some immune-mediated diseases. Arthritis Rheum. 2008 Sep;58(9):2598–2602. doi: 10.1002/art.23792. [DOI] [PubMed] [Google Scholar]
  • 8.Barton A, Thomson W, Ke X, Eyre S, Hinks A, Bowes J, et al. Re-evaluation of putative rheumatoid arthritis susceptibility genes in the post-genome wide association study era and hypothesis of a key pathway underlying susceptibility. Hum Mol Genet. 2008 Aug 1;17(15):2274–2279. doi: 10.1093/hmg/ddn128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kelley J, Hughes L, Faggard J, Danila M, Crawford M, Edberg Y, et al. An African ancestry-specific allele of Cytotoxic T-Lymphocyte Associated Protein 4 (CTLA4) confers protection against rheumatoid arthritis in African-Americans. PLoS Genet. 2009 doi: 10.1371/journal.pgen.1000424. in press. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

RESOURCES